Pitti Group Wealth Management LLC boosted its position in Ultralife Co. (NASDAQ:ULBI – Free Report) by 41.3% during the 4th quarter, Holdings Channel reports. The fund owned 18,120 shares of the technology company’s stock after buying an additional 5,300 shares during the period. Pitti Group Wealth Management LLC’s holdings in Ultralife were worth $124,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds have also added to or reduced their stakes in the company. EAM Investors LLC bought a new position in shares of Ultralife in the third quarter valued at approximately $1,776,000. Acadian Asset Management LLC bought a new position in shares of Ultralife in the third quarter valued at approximately $1,039,000. Connor Clark & Lunn Investment Management Ltd. bought a new position in shares of Ultralife in the third quarter valued at approximately $641,000. ClariVest Asset Management LLC bought a new position in shares of Ultralife in the third quarter valued at approximately $616,000. Finally, Barclays PLC bought a new position in shares of Ultralife in the third quarter valued at approximately $127,000. Institutional investors own 30.68% of the company’s stock.
Ultralife Stock Performance
Shares of NASDAQ:ULBI traded up $0.68 during midday trading on Friday, reaching $11.39. 253,864 shares of the company traded hands, compared to its average volume of 77,117. The company has a quick ratio of 2.02, a current ratio of 3.80 and a debt-to-equity ratio of 0.19. Ultralife Co. has a 12 month low of $3.92 and a 12 month high of $11.85. The firm has a market capitalization of $187.38 million, a price-to-earnings ratio of 17.80 and a beta of 1.26. The firm’s fifty day moving average price is $9.20 and its two-hundred day moving average price is $8.21.
Analyst Upgrades and Downgrades
A number of research analysts have recently weighed in on the company. StockNews.com upgraded Ultralife from a “buy” rating to a “strong-buy” rating in a report on Wednesday. Benchmark boosted their target price on Ultralife from $12.00 to $13.00 and gave the company a “buy” rating in a research note on Tuesday, March 5th.
Read Our Latest Research Report on ULBI
About Ultralife
Ultralife Corporation, together with its subsidiaries, designs, manufactures, installs, and maintains power, and communication and electronics systems worldwide. The company operates in two segments, Battery & Energy Products and Communications Systems. The Battery & Energy Products segment offers lithium 9-volt, cylindrical, thin lithium manganese dioxide, rechargeable, and other non-rechargeable batteries; lithium-ion cells, multi-kilowatt module lithium-ion battery systems, and uninterruptable power supplies; and rugged military and commercial battery charging systems and accessories, including smart chargers, multi-bay charging systems, and various cables.
Read More
- Five stocks we like better than Ultralife
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- MarketBeat Week in Review – 4/22 – 4/26
- Ride Out The Recession With These Dividend Kings
- 3 Stocks Leading the U.S. Agriculture Comeback
- High Dividend REITs: Are They an Ideal Way to Diversify?
- How to Use Put Debit Spreads to Profit From Falling Stocks
Want to see what other hedge funds are holding ULBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ultralife Co. (NASDAQ:ULBI – Free Report).
Receive News & Ratings for Ultralife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ultralife and related companies with MarketBeat.com's FREE daily email newsletter.